Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)

NCT00099463 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Healthy

Interventions

PROCEDURE: Blood Test
PROCEDURE: Urine Test
PROCEDURE: Physical Exam
DRUG: Vaccine
DRUG: VRC-SRSDNA015-00-VP

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)